{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:25:28Z","timestamp":1780539928574,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_157448"],"award-info":[{"award-number":["PP00P3_157448"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ymthe.2023.11.026","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:17:59Z","timestamp":1701800279000},"page":"426-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A replicating LCMV-based vaccine for the treatment of solid tumors"],"prefix":"10.1016","volume":"32","author":[{"given":"Mette-Triin","family":"Purde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Cupovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick A.","family":"Palmowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Makky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rochwarger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stemeseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bomze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiamma","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Ludewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus K.","family":"Orlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schietinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-8390","authenticated-orcid":false,"given":"Lukas","family":"Flatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.11.026_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.11.026_bib2","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","article-title":"Immune escape to PD-L1\/PD-1 blockade: seven steps to success (or failure)","volume":"27","author":"Kim","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib3","article-title":"Real-world experience with pembrolizumab in patients with advanced melanoma: A large retrospective observational study","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymthe.2023.11.026_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.578091","article-title":"First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050989","article-title":"Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?","volume":"13","author":"Albandar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2023.11.026_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2018.03.008","article-title":"The Immune Revolution: A Case for Priming, Not Checkpoint","volume":"33","author":"Vonderheide","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2023.11.026_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/v11020156","article-title":"Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus","volume":"11","author":"Kahan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.11.026_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/eji.1830230722","article-title":"Lysis of infected cells in\u00a0vivo by antiviral cytolytic T\u00a0cells demonstrated by release of cell internal viral proteins","volume":"23","author":"Kyburz","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1084\/jem.169.6.1993","article-title":"T cell memory. Long-term persistence of virus-specific cytotoxic T\u00a0cells","volume":"169","author":"Jamieson","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.11.026_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T\u00a0cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.11.026_bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2016.03.005","article-title":"Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection","volume":"34","author":"Cardin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2023.11.026_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/infdis\/jiaa121","article-title":"A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus","volume":"225","author":"Schwendinger","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.11.026_bib13","article-title":"Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive HBV-specific CD8 T\u00a0cell responses and high anti-HBs titers","author":"Schmidt","year":"2023","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.11.026_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8(+) T\u00a0cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.11.026_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1809960","article-title":"Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer","volume":"9","author":"Schmidt","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2023.11.026_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/j.1460-2075.1992.tb05083.x","article-title":"A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus","volume":"11","author":"Jackson","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2023.11.026_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4939-3389-1_24","article-title":"Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors","volume":"1404","author":"Ring","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib19","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.4049\/jimmunol.179.10.6725","article-title":"Duration of antigen expression in\u00a0vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes","volume":"179","author":"Hovav","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.11.026_bib21","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/MCB.24.8.3396-3403.2004","article-title":"Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice","volume":"24","author":"Guyonneau","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20021910","article-title":"Signal 3 determines tolerance versus full activation of naive CD8 T\u00a0cells: dissociating proliferation and development of effector function","volume":"197","author":"Curtsinger","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.11.026_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.0105-2896.2009.00881.x","article-title":"Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance","volume":"234","author":"Swiecki","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2023.11.026_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.seminoncol.2015.05.011","article-title":"The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment","volume":"42","author":"Gajewski","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T\u00a0cells to allow optimal antiviral T\u00a0cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.11.026_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101134","article-title":"The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis","volume":"41","author":"Li","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2023.11.026_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2020.09.048","article-title":"Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation","volume":"183","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.11.026_bib28","article-title":"Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690499","article-title":"Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-016-0367-1","article-title":"T-cell receptor-engineered T\u00a0cells for cancer treatment: current status and future directions","volume":"9","author":"Ping","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2023.11.026_bib31","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41596-021-00556-8","article-title":"CODEX multiplexed tissue imaging with DNA-conjugated antibodies","volume":"16","author":"Black","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.11.026_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2023.11.026_bib33","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1001\/jama.284.23.3040","article-title":"Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls","volume":"284","author":"Chang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2023.11.026_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.11.026_bib35","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1102495","article-title":"CD8 T\u00a0cell priming in the presence of IFN-alpha renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T\u00a0cell therapy","volume":"189","author":"Hervas-Stubbs","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib36","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T\u00a0cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.11.026_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002371-200001000-00004","article-title":"Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma","volume":"23","author":"Kawakami","year":"2000","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2023.11.026_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2006893","article-title":"Keratinocyte differentiation antigen-specific T\u00a0cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival","volume":"10","author":"Berner","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2023.11.026_bib39","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.11.026_bib40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.11.026_bib41","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.molonc.2015.10.018","article-title":"Tumor-infiltrating lymphocytes for the treatment of metastatic cancer","volume":"9","author":"Geukes Foppen","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option","volume":"6","author":"Rohaan","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2023.11.026_bib43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PPO.0000000000000157","article-title":"Toxicities Associated With Adoptive T-Cell Transfer for Cancer","volume":"21","author":"Yang","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.ymthe.2023.11.026_bib44","doi-asserted-by":"crossref","first-page":"W401","DOI":"10.1093\/nar\/gku410","article-title":"CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing","volume":"42","author":"Montague","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2023.11.026_bib45","doi-asserted-by":"crossref","first-page":"W272","DOI":"10.1093\/nar\/gkw398","article-title":"CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering","volume":"44","author":"Labun","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2023.11.026_bib46","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1158\/0008-5472.CAN-06-4372","article-title":"Decreased tumor surveillance after adoptive T-cell therapy","volume":"67","author":"Matter","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.11.026_bib47","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1158\/0008-5472.CAN-06-0399","article-title":"Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice","volume":"66","author":"Tormo","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.11.026_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/0008-5472.CAN-12-1123","article-title":"High-avidity T\u00a0cells are preferentially tolerized in the tumor microenvironment","volume":"73","author":"Zhu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.11.026_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"Euhus","year":"1986","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib51","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front","volume":"182","author":"Schurch","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.11.026_bib52","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/eji.202048891","article-title":"Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction","volume":"51","author":"Kennedy-Darling","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib53","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-021-26974-6","article-title":"Immune cell topography predicts response to PD-1 blockade in cutaneous T\u00a0cell lymphoma","volume":"12","author":"Phillips","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.11.026_bib54","article-title":"A single cell spatial temporal atlas of skeletal muscle reveals cellular neighborhoods that orchestrate regeneration and become disrupted in aging","author":"Wang","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2023.11.026_bib55","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/eji.201041235","article-title":"Combination of lentivector immunization and low-dose chemotherapy or PD-1\/PD-L1 blocking primes self-reactive T\u00a0cells and induces anti-tumor immunity","volume":"41","author":"Sierro","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.026_bib56","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:45:40Z","timestamp":1777617940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623006597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1525001623006597"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A replicating LCMV-based vaccine for the treatment of solid tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}